The compounding pharmacy market, valued at approximately USD 15.1 billion in 2025, is forecast to reach nearly USD 20 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7%, says ...

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.

An ordered pharmaceutical compounding process for use in 503A pharmacies, 503B outsourcing facilities, pharmaceutical industry, and other applications. Compounded pharmaceutical dosage forms may be ...

The first licensed 503A compounding pharmacy offering THC-free, prescription-only CBD in the country launched in Colorado.

Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling. Performing calculations for the formulation of pharmaceutical dosage forms and ...

Unlike conventional pharmacies, which mostly dispense premade drugs in standard doses, compounding pharmacies make, or "compound," medications on the premises, according to federal guidelines. For ...

Lawsuit alleges anti-competitive conduct designed to suppress lawful compounding pharmaceuticals and limit patient choice ...

It is easy to differentiate between your local community pharmacy and a large pharmaceutical manufacturer. The pharmacy is viewed as dispensing medications to particular patients with prescriptions ...

A year ago, the FDA took the unusual step of inserting itself into the controversy over the KV Pharmaceutical drug known as Makena, which the agency had approved for premature births under the Orphan ...

Kazmira Therapeutics announced today the official launch of a first-of-its-kind, prescription-only cannabinoid (CBD) pharmacy, Kazmira Pharmacy. This licensed and LegitScript certified 503A ...